Do≥Īczy≥: 10 Paľ 2017
|Wys≥any: Wto Paľ 10, 2017 06:19 Temat postu: Evaluation of sHLA-G levels in serum of patients with prosta
|Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.
Prostate cancer Prostatitis Treatment is the most common
Prostatitiscancer type in men and is the second
cause of death, Chronic Prostatitis due to cancer,
in patients over 50 Chronic Pelvic Pain Syndrome ,
after lung cancer BPH Treatment . Prostate specific antigen
(PSA) is a widely used Blood In Semen tumor marker for prostate cancer.
Recently Blood in Urine,
PSA is discovered in non-prostatic Burning While Urinating cancer
tissues in men and women Difficulty Urinatingraising doubts about
its specificity for prostatic tissues Pain While Urinating.
PSA exists in low serum level in healthy Frequent Urination men and in higher levels
in many prostate disorders, including prostatitis and prostate cancer Painful Ejaculation.
Thus, a supplementary tumor marker is needed to Prostatitis Antibiotics accurately
diagnose the cancer and to observe the patient after treatment Treatment of Prostatitis.
Recently, soluble human leukocyte antigen-G (sHLA-G) Chronic Prostatitis Symptomshas been introduced as a new
tumor marker for different cancer types Prostatic Hypertrophy,
including colorectal, breast, lung, and ovary.Nonbacterial Prostatitis The
present descriptive-experimental study was carried out including patients Causes of Prostatitis
with malignant prostate tumor,Amoxicillin Prostatitis patients with benign
prostate tumor, and a group of health men as the control group Treatment for BPH,
as judged by an oncologist as well as a pathologist. After sterile blood sampling,Doxycycline Prostatitis sHLA-G was measured by
enzyme-linked immunosorbent assay in each group. ProstatectomyThe data was then
analyzed using one-way ANOVA. P≤0.05 was BPH Symptoms considered as statistically significant.
The results showed that the mean of sHLA-G level was high in patients. Also, it was found that there was a significant difference
in sHLA serum level between the three groups. Prostatitis Cure The data revealed that sHLA-G can be a novel supplementary tumor marker in addition to
PSA to diagnose prostate cancer.